Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Transcranial photobiomodulation (laser) therapy for cognitive impairment: A review of molecular mechanisms and potential application to canine cognitive dysfunction (CCD)

Improvement in cognitive ability using tPBMT has been documented in rodent AD models and human clinical trials.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This review examines how transcranial photobiomodulation, which delivers near-infrared and infrared light through the scalp to the brain, may act at the molecular level to address cognitive decline. The authors also propose applying this approach to dogs with canine cognitive dysfunction, a condition they describe as a naturally occurring model of Alzheimer's disease. The abstract notes that cognitive improvement has been documented in rodent Alzheimer's models and human clinical trials, but it does not report any new experimental results from this review.

Who or what was studied
Review of rodent Alzheimer's models, human clinical trials and dogs with canine cognitive dysfunction (no specific numbers stated)
Limits stated in the abstract
The abstract describes a review and proposal without reporting a specific number of studies, participants or outcome measures.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ejmanager.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Laser, Photobiomodulation therapy, Cognitive decline. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Brain & Neurology

Chronic 40-hz light-emitting diode (LED) therapy attenuates cognitive and behavioral deficits and modulates BDNF and caspase-3 expression in a D-galactose/aluminum chloride-induced sporadic Alzheimer's-like rat model

These data suggest that 40-Hz LED stimulation confers neuroprotection in the D-gal/AlCl3-induced AD model, potentially through enhancement of neurotropic signaling and inhibition of apoptosis, supporting its promise as a non-invasive strategy against neurodegenerative decline.

Study · August 7, 2026 · Ghorbani E et al.